Investigating Various Thresholds as Immunohistochemistry Cutoffs for Observer Agreement

Asif Ali1, Sarah Bell, Alan Bilsland

  • 1*Institute of Cancer Sciences, College of Medical, Veterinary and Life Sciences, University of Glasgow §Institute of Cardiovascular and Medical Sciences, University of Glasgow, Western Infirmary ¶Academic Unit of Surgery, School of Medicine, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow Royal Infirmary ‡Department of Pathology, Laboratory Medicine Building, Queen Elizabeth University Hospital, Greater Glasgow & Clyde NHS ∥West of Scotland Pancreatic Unit and Glasgow Royal Infirmary, Alexandra Parade, Glasgow #Pathology Laboratory, Forth Valley Royal Hospital, Larbert, UK †Institute of Basic Medical Sciences, Khyber Medical University, Peshawar, Pakistan.

Insights

Three common immunohistochemistry (IHC) cutoffs for biomarker interpretation show reasonable observer agreement, enhancing reproducibility in cancer pathology. These thresholds help reduce variability in staining interpretation among pathologists.

Area of Science:

  • Pathology
  • Biomarker Discovery
  • Cancer Research

Background:

  • Clinical translation of immunohistochemistry (IHC) biomarkers necessitates reliable interpretation cutoffs.
  • Current research often prioritizes biomarker clinical utility over observer agreement.
  • Three common IHC cutoffs (10% positive cells, 20% positive cells, moderate-to-strong intensity) were selected for analysis.

Purpose of the Study:

  • To assess interobserver and intraobserver agreement for commonly used IHC interpretation cutoffs.
  • To evaluate the reproducibility of IHC biomarker interpretation among pathologists.
  • To determine if specific staining patterns influence agreement.

Main Methods:

  • A set of 36 IHC-stained microarray core images with variable staining was scored by seven pathologists.
  • Three predefined cutoffs (10% positive cells, 20% positive cells, +2/+3 intensity) were used for scoring.
  • Kappa (κ) statistic was employed to quantify interobserver and intraobserver agreement.

Main Results:

  • Reasonably good interobserver agreement was observed across all three cutoffs (mean κ: 0.59–0.64).
  • Experienced pathologists showed better agreement with the 10% cutoff compared to junior pathologists.
  • Good intraobserver agreement was also achieved (mean κ: 0.60–0.73), with higher agreement for cytoplasmic-only staining.

Conclusions:

  • The investigated IHC cutoffs demonstrate reasonable agreement, reducing interpretation variability.
  • These established cutoffs are reproducible among practicing pathologists, supporting their clinical utility.
  • The findings provide evidence for the reliability of these thresholds in cancer pathology.
Abstract